01 March 2006
Transforaminal lumbar interbody fusion: An independent assessment of outcomesin a difficult patient population.
Bradley K. Weiner, Hoan-Vu Nguyen, S. Will HazardMed Sci Monit 2006; 12(3): CR99-102 :: ID: 447105
Abstract
Background: Transforaminal lumbar interbody fusion is becoming increasinglypopular for the surgical treatment of lumbar degenerative conditions. However, the outcomes followingthe procedure have only begun to be evaluated. Material/Methods: The authors reviewed all patients previouslytreated by TLIF at our tertiary center with minimum two year follow-up. Between 1997 and 2001, twenty-sevenpatients underwent the procedure. They were evaluated clinically and radiographically at regular intervalsfor a minimum two years following surgery and longer term follow-up was carried out by telephone interview.Long-term follow-up was undertaken by an independent assessor (a spine surgeon not directly involvedin the patient's care) and outcomes were assessed using the measure designed by Macnab/McCulloch/An.Follow-up averaged 30 months and ranged from 24 to 42 months. Results: All but two patients obtaineda solid radiographic arthrodesis and complications were few. However, only eleven patients obtained excellentor good clinical results, while 16 had fair or poor outcomes. Conclusions: TLIF is a technically demandingprocedure which can be done with relatively few complications and offers excellent rates of arthrodesis.However, the outcomes of the procedure and indications for the procedure in difficult patient populationsclearly require further study.
Keywords: Diskectomy - statistics & numerical data, Evaluation Studies as Topic, Follow-Up Studies, Laminectomy - statistics & numerical data, Spinal Diseases - surgery, Spinal Fusion - statistics & numerical data, Time Factors
Editorial
01 May 2024 : Editorial
Editorial: First Regulatory Approval for Adoptive Cell Therapy with Autologous Tumor-Infiltrating Lymphocytes (TILs) – Lifileucel (Amtagvi)DOI: 10.12659/MSM.944927
Med Sci Monit 2024; 30:e944927
In Press
11 Mar 2024 : Clinical Research
Enhancement of Frozen-Thawed Human Sperm Quality with Zinc as a Cryoprotective AdditiveMed Sci Monit In Press; DOI: 10.12659/MSM.942946
12 Mar 2024 : Database Analysis
Risk Factors of Age-Related Macular Degeneration in a Population-Based Study: Results from SHIP-TREND-1 (St...Med Sci Monit In Press; DOI: 10.12659/MSM.943140
12 Mar 2024 : Clinical Research
Preoperative Blood Transfusion Requirements for Hemorrhoidal Severe Anemia: A Retrospective Study of 128 Pa...Med Sci Monit In Press; DOI: 10.12659/MSM.943126
12 Mar 2024 : Clinical Research
Tissue Inhibitors of Metalloproteinase 1 (TIMP-1) and 3 (TIMP-3) as New Markers of Acute Kidney Injury Afte...Med Sci Monit In Press; DOI: 10.12659/MSM.943500
Most Viewed Current Articles
17 Jan 2024 : Review article
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
14 Dec 2022 : Clinical Research
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
16 May 2023 : Clinical Research
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952